HoustonBionics is a pioneering company focused on transforming stroke recovery through high-tech, at-home rehabilitation solutions. Founded in 2021, the company combines innovation with accessibility, addressing a critical need in the healthcare industry. Their flagship product, ExoRehab X, provides a comprehensive solution for upper extremity rehabilitation at home, enhancing patient compliance and improving recovery outcomes.
The technology behind ExoRehab X is grounded in rigorous research from Rice University and developed in collaboration with the Texas Medical Center. This equipment integrates seamlessly into existing healthcare protocols, ensuring continuous patient support post-discharge. By collaborating with health systems and clinics, HoustonBionics ensures that stroke survivors receive consistent and high-quality care, regaining their independence efficiently.
Recently, HoustonBionics secured a seed investment from Cross Ocean Ventures on 01 January 2022. Positioned at the intersection of Manufacturing and Medical Devices, the company is poised for significant growth and impact in the healthcare sector. Investors should note their mission to make stroke recovery more connected and accessible.